News: RUL Rpmglobal expects full year operating EBITDA for FY2017 to be $4.6 million, page-5

First 5 Last

Share
Profile

Follow
Just_a_guy

5,426 Posts.

298

16/12/17

10:22

Post #: 29676497
Share

Originally posted by Jimmy_C ↑

That's not an entirely unfair comment. There's a difference between paying commissions to the software sales team and/or distributors - that's their job and if they sell, they should earn, just like any other commission-based role - and appropriately incentivising senior management. $3m in short-term bonus payments have been triggered for senior management this year, and this is linked to "adjusted EBIT" with targets set by the board - the issues i see with this are:

1) The targets set by the board appear to be too low - to trigger $3m short-term incentives for senior management on $4.6m operating EBITDA fails the reasonableness smell test. The implication is that pre-bonus EBITDA was $7.6m, and assuming FY17 D&A was ~$2m (in line with FY16), then pre-bonus EBIT was ~$5.6m. So management have, in effect, eaten >50% of FY17's EBIT in short-term bonus payments - that just fails the smell test.

2) The hurdle is "adjusted EBIT" which means management can take various expenses below the line to hit their bonus target. In addition, RUL capitalises part of its software R&D expense which could potentially lead to an inflated view of "adjusted EBIT" relative to cash performance of the business (although the capitalised cost should roughly equal the amortisation charge over time and wash through).

Interesting business at an apparent positive inflection point, although the board needs to rethink short-term incentive structures.

Expand

If RUL is at an inflexion point, and EBITDA continues to rise, will the bonuses continue to rise too or do you think the 3mil bonus is max'd out, i.e if ebitda grows to 15mil, will the bonuses stay at 3 mil or grow to 7-8mil?

Did anyone attend the agm? Was there any talk of senior management skimming all the cream?

RUL Price at posting: 65.0¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

PAR

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.91		Change 0.015(0.52%)		Mkt cap ! $642.2M

Open	High	Low	Value	Volume
$2.87	$2.92	$2.86	$146.5K	50.84K

Buyers (Bids)

No.	Vol.	Price($)
8	9524	$2.90

Sellers (Offers)

Price($)	Vol.	No.
$2.91	1399	3

View Market Depth

No.	Vol.	Price($)
7	8940	2.900
5	2461	2.890
14	3664	2.880
6	33233	2.870
6	7281	2.860

Price($)	Vol.	No.
2.910	2369	4
2.920	4432	8
2.930	4539	7
2.940	8476	6
2.950	46984	7

Last trade - 13.50pm 26/06/2025 (20 minute delay)

RUL (ASX) Chart

News: RUL Rpmglobal expects full year operating EBITDA for FY2017 to be $4.6 million, page-5

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

News: RUL Rpmglobal expects full year operating EBITDA for FY2017 to be $4.6 million, page-5

Top Stories

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News